Financial Markets
Alembic Pharma gains after receiving US FDA nod for psoriasis treatment drug Acitretin
Alembic Pharmaceuticals advanced 2.67% to Rs 1216.10 after the company received final approval from the US Food & Drug Administration (US FDA) for its abbreviated new drug application (ANDA) Acitretin Capsules.
Related
Share this page
Guest Posts by Easy BranchesGet Reliable Matka Guessing Forum with our Satta Matka Expert and Get all Matka Chart For Free.